Literature DB >> 17726016

Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation.

Sung-Wuk Jang1, Seung-Ju Yang, Shanthi Srinivasan, Keqiang Ye.   

Abstract

Oxidative stress can induce apoptosis through activation of MstI, subsequent phosphorylation of FOXO and nuclear translocation. MstI is a common component of apoptosis initiated by various stresses. MstI kinase activation requires autophosphorylation and proteolytic degradation by caspases. The role of Akt in regulating MstI activity has not been previously examined. Here, we show that MstI is a physiological substrate of Akt. Akt phosphorylation of MstI diminishes its apoptotic cleavage by caspases and prevents its kinase activity on FOXO3. MstI directly binds to Akt, which is regulated Akt kinase activity. Akt phosphorylates MstI on the Thr(387) residue and protects MstI from apoptotic cleavage in vitro and in apoptotic cells. Interestingly, Akt phosphorylation of MstI strongly inhibits its kinase activity on FOXO3. The phosphorylation mimetic mutant MST1 T387E blocks H2O2-triggered FOXO3 nuclear translocation and apoptosis. Thus, our findings support that Akt blocks MstI-triggered FOXO3 nuclear translocation by phosphorylating MstI, promoting cell survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726016     DOI: 10.1074/jbc.M704542200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.

Authors:  Kyung-Ah Park; Nuri Yun; Dong-Ik Shin; So Yoen Choi; Hyun Kim; Won-Ki Kim; Yuzuru Kanakura; Hirohiko Shibayama; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2010-10-06       Impact factor: 3.575

2.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

3.  Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts.

Authors:  Chih-Hsueh Lin; Cheng-Chieh Lin; Wei-Jen Ting; Pei-Ying Pai; Chia-Hua Kuo; Tsung-Jung Ho; Wei-Wen Kuo; Chung-Ho Chang; Chih-Yang Huang; Wan-Teng Lin
Journal:  Age (Dordr)       Date:  2014-08-27

Review 4.  Regulation of mammalian Ste20 (Mst) kinases.

Authors:  Sonali J Rawat; Jonathan Chernoff
Journal:  Trends Biochem Sci       Date:  2015-02-06       Impact factor: 13.807

Review 5.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 6.  MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.

Authors:  Amin Ardestani; Kathrin Maedler
Journal:  Diabetologia       Date:  2016-04-06       Impact factor: 10.122

7.  Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.

Authors:  David Romano; David Matallanas; Gregory Weitsman; Christian Preisinger; Tony Ng; Walter Kolch
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

8.  Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.

Authors:  Amrik Singh; Min Ye; Octavian Bucur; Shudong Zhu; Maria Tanya Santos; Isaac Rabinovitz; Wenyi Wei; Daming Gao; William C Hahn; Roya Khosravi-Far
Journal:  Mol Biol Cell       Date:  2010-01-28       Impact factor: 4.138

9.  Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway.

Authors:  Donghwa Kim; Shaokun Shu; Marc D Coppola; Satoshi Kaneko; Zeng-Qiang Yuan; Jin Q Cheng
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

10.  Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice.

Authors:  Juhyun Choi; Sangphil Oh; Dongjun Lee; Hyun Jung Oh; Jik Young Park; Sean Bong Lee; Dae-Sik Lim
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.